Stem Cells Market Is Projected To Witness Growth Based On Increasing Increasing R&D To Develop Therapeutic Solution For Chronic Diseases Till 2020:Grand View Research,inc.
The global stem cells market size is expected to reach USD
170.15 billion by 2020, according to a new report by Grand View Research, Inc.
The market is expected to grow because of increasing research and development
to develop therapeutic solution for chronic diseases and the huge funding by
the government for drug discovery and development to serve the large unmet
medical needs.
The WHO statistics on Cancer
(2012) concluded that it is the leading cause for global mortality and
morbidity, with around 14 million new cancer cases and 8.2 million cancer
related deaths which is estimated to reach 22 million in next two decades. Stem
cells in combination with gene therapy along with DNA repair is anticipated to
be used to treat many intractable diseases and is classified under orphan
drugs.
The California’s Stem Cell Agency
has spent around USD 1.4 billion for stem cell research and still has USD 872
million to provide for the same. In addition to this, in 2013 the National
Institute of Health has funded around USD1.3 million stem cell researches.
Browse full research report on Stem Cells Market: http://www.grandviewresearch.com/industry-analysis/stem-cells-market
Adult stem cell leads the market
due to low contamination during sub-culture and expansion, relatively low labor
production and compatibility with the human body. Induced pluripotent stem
cells are expected to report revenue of over USD 4.5 billion by 2020, on
account of analogous nature of its origin.
Different types of technologies
include cell acquisition, cryopreservation, cell production, expansion and
sub-culture. For any technique in stem cell production, stem cell acquisition
is the basic step; hence, this segment is likely to dominate the market with
revenues estimated at USD 10.9 billion by 2020.
Application of stem cell in
regenerative medicines is exponentially increasing and hence dominates the
market as compared to its application in drug discovery and medicine.
Geographical presence of stem cell market is in North America, Asia Pacific,
Europe and rest of the world. North America held the largest industry share due
to huge government funding and initiative for stem cell research and rise in the
acceptance of stem cell therapies.
However, Asia-Pacific is expected
to be the fastest growing segment with a CAGR of over 25.0% due to rising
contract research outsourcing and medical tourism. Key industry contributors
include Advanced Cell Technology Inc., CellartisAB, Cellular Engineering
Technologies Inc., BioTime Inc. and International Stem Cell Corporation.
In March 2015, International Stem
Cell Corporation received patent from Japan for it human cell bank production
from pathogenically activated eggs. This is in alignment with the companies’
strategy to make its intellectual property position strong and also develop
relationship with Japan. Moreover, in June 2015, Cellaris AB launched a new
xeno free culture called Cellartis EF-CS.
Factors such as government
funding, key player engagement to update the techniques, collaboration with
domestic players for country specific market entry are expected to boom the
stem cell market.
Browse more reports of this category by Grand View
Research: http://www.grandviewresearch.com/industry/biotechnology
Grand View Research has segmented the global stem cells
market on the basis of product,
application, technology and region:
Stem Cells Product Outlook
- Stem
Cells Platforms
- Sequence
Analysis Platforms
- Adult
Stem Cells
- Hematopoietic
Stem Cells
- Mesenchymal
Stem Cells
- Neuronal
Stem Cells
- Dental
Stem Cells
- Umbilical
Cord Stem Cells
- Human
Embryonic Stem Cells
- Induced
Pluripotent Stem Cells
- Natural
Rosette Cells
- Very
Small Embryonic Like Stem Cells
Stem Cells Application Outlook
- Regenerative
Medicine
- Neurology
- Orthopedics
- Oncology
- Hematology
- Cardiovascular
and Myocardial Infraction
- Injuries
- Diabetes
- Liver
Disorder
- Incontinence
- Others
(Crohn’s Disease, Infertility, Immunodeficiency Disorder, Organ
Transplants, Ophthalmic Disorder)
- Drug
Discovery and Development
Stem Cells Technology Outlook
- Cell
Acquisition
- Bone
Marrow Harvest
- Apheresis
- Umbilical
Blood Cord
- Cell
Production
- Therapeutic
Cloning
- In
Vitro Fertilization
- Isolation
- Cell
Culture
- Cryopreservation
- Expansion
and Sub-Culture
Stem Cells Regional Outlook
- North
America
- Europe
- Asia
Pacific
- RoW
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting services.
To help clients make informed business decisions, we offer market intelligence
studies ensuring relevant and fact-based research across a range of industries,
from technology to chemicals, materials and healthcare.
Comments
Post a Comment